AKT1 and mucoepidermoid carcinoma: Recently, Alamri et al. (2018) have shown that allosteric AKT inhibitor MK2206 can inhibit the growth of Mucoepidermoid carcinoma (MEC) cells in 2d and 3d CR culture [26].